Risk factors for the prognosis of colon cancer

doi:10.4251/wjgo.v16.i8.3738

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (669)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

487

Sum=522

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=115

Aug 15, 2024 (publication date) through Nov 9, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3738-3740
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3738

Risk factors for the prognosis of colon cancer

Chu-Ying Wu, Kai Ye

Chu-Ying Wu, Kai Ye, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China

Author contributions: Wu CY contributed to original draft preparation, writing and editing; Kai Y contributed to conceptualization, supervision, and funding acquisition; all authors have read and approved the final manuscript.

Supported by Key Clinical Specialty Discipline Construction Program of Fujian, Fujian Health Medicine and Politics, No. [2022] 884.

Conflict-of-interest statement: All authors report no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Kai Ye, MD, Chief Doctor, Dean, Professor, Research Dean, Surgeon, Surgical Oncologist, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, No. 950 Donghai Street, Quanzhou 362000, Fujian Province, China. medwcy@163.com

Received: May 19, 2024
Revised: June 25, 2024
Accepted: July 8, 2024
Published online: August 15, 2024
Processing time: 80 Days and 22.6 Hours

Core Tip

Core Tip: The incidence and mortality rates of colon cancer are increasing; while most cases involve advanced-stage disease, T4-stage disease is rare and poorly studied. Survival time is an important indicator of treatment effectiveness, and this study identified multiple independent risk factors. T4-stage cancer invades the entire thickness of the intestinal tract, increasing the difficulty of treatment and the risk of recurrence, and requires a combination of multiple treatment methods. The prognosis of right hemicolectomy is worse than that of left hemicolectomy, and right hemicolectomy is an independent risk factor for a poor prognosis. Advanced age, histopathological type, and lymph node metastasis are also risk factors.